PSI Newsletter 2025
Browse our 2025 PSI Newsletters.
PSI Newsletter: Issue 1, 2025
Read the updates and insights in the PSI Newsletter: Issue 1, 2025
- Continuing Professional Development (CPD) system changes
- Election for appointment of pharmacists to PSI Council
- Expansion of the role of pharmacy
- Learning from a PSI Inquiry
- Healthmail clarification
- Valproate (Epilim▼) materials for patients
- Safe dispensing of controlled drugs
- Fitness to practise and mediation outcomes
- HSE-AMRIC resource
- Spring COVID-19 booster campaign
- Pharmacy needle exchange survey
- Opportunities for pharmacists on HSE working groups
PSI Newsletter: Issue 2, 2025
Read the updates and insights in the PSI Newsletter: Issue 2, 2025
- Updates to vaccination and emergency medicines training requirements for pharmacists
- Expansion of pharmacy services: Public consultation on proposed education and training rules and guidelines
- Public consultation: Registration Rule changes to facilitate a delineated model of operation
- Accreditation of MPharm degree programmes
- ePortfolio Review 2025/2026
- EMA review on Finasteride and Dutasteride
- Direct healthcare professional communications – feasibility study
- PSI Council appointments
- Fitness to practise matter
- Safe dispensing of Roaccutane® (isotretinoin)
- Updates to PSI Guidance on Good Dispensing Practice-High Tech Arrangements
- Ceftriaxone use in long term residential care facilities
- PPC Annual Reports
- Notice on hub and spoke model of dispensing
- Changes to pharmacy layouts and floorplans